Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding.
about
Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Use of recombinant activated f ...... tients with critical bleeding.
@en
Use of recombinant activated f ...... tients with critical bleeding.
@nl
type
label
Use of recombinant activated f ...... tients with critical bleeding.
@en
Use of recombinant activated f ...... tients with critical bleeding.
@nl
prefLabel
Use of recombinant activated f ...... tients with critical bleeding.
@en
Use of recombinant activated f ...... tients with critical bleeding.
@nl
P2093
P2860
P1476
Use of recombinant activated f ...... tients with critical bleeding.
@en
P2093
Amanda J Zatta
Australian and New Zealand Haemostasis Registry Steering Committee
James P Isbister
Louise E Phillips
Naomi J Aoki
P2860
P304
P356
10.1111/J.1445-2197.2012.06285.X
P577
2012-10-04T00:00:00Z